| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 3 | |
| #2 | Mexico | 3 | |
| #3 | Republic of Korea | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | China | 1 | |
| #8 | Israel | 1 | |
| #9 | India | 1 | |
| #10 | New Zealand | 1 | |
| #11 | Philippines | 1 | |
| #12 | Singapore | 1 | |
| #13 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Yager Kraig M | 9 |
| #2 | Judd Weston R | 7 |
| #3 | Murphy Brett R | 7 |
| #4 | Lockman Jeffrey W | 7 |
| #5 | Mullan Michael J | 6 |
| #6 | Paris Daniel | 6 |
| #7 | Willardsen J Adam | 6 |
| #8 | Shenderovich Mark D | 5 |
| #9 | Richards Burt | 4 |
| #10 | Mcleod Donald A | 4 |
| Publication | Filing date | Title |
|---|---|---|
| MX2015000101A | Compounds and therapeutic uses thereof. | |
| WO2014004863A2 | Compounds, compositions, and therapeutic uses thereof | |
| TW200920364A | Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer |